Accord Sees Two Hybrids Endorsed By EU’s CHMP
Doxorubicin And Leuprorelin Products Lined Up In Europe
The latest CHMP meeting has seen the EMA committee issue a positive opinion on two Accord hybrid medicines, Zolsketil (doxorubicin) and Camcevi (leuprorelin), at the same time as SERB’s generic amifampridine tablets were also endorsed.
